Stephanie Beno: Cannabis Patent Approved for Cancer Treatment
Stephanie Beno, Founder and Owner of Persephone Cannabis, shared a post on LinkedIn:
”Big News: Cannabis Patent Approved for Cancer Treatment!
I’m incredibly proud to announce that our patent for Terpene Control in Scalable Cannabinoid Medicinal Formulations, focused on cancer treatment, has officially been approved!
This makes another patent under our IP Portfolio.
This achievement marks a huge step forward in using cannabis-based formulations to provide relief for cancer patients. Our research and development have demonstrated the potential of cannabinoids to significantly impact cancer treatment, and we’re excited to contribute to the future of oncology care.
A big thank you to everyone who supported us along the way—this success is shared by our dedicated team and partners. We’re looking forward to bringing these innovations to those who need them the most!
- Patent No.: US 12,076,308 B2.
- Date of Patent: September 3, 2024.”
Source: Stephanie Beno/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023